Deutsche Bank Portfolio holdings
Deutsche Bank AG, founded in 1870 to finance German exports and headquartered in Frankfurt, Germany, is a leading global investment bank with a significant presence in commercial banking, wealth management, and asset management, managing billions in assets across Europe, the Americas, and Asia. Known for its expertise in trading, corporate finance, and mergers and acquisitions, it serves corporations, governments, and institutional clients, though it has faced challenges, including hefty fines and restructuring efforts following the 2008 financial crisis and subsequent scandals. Under CEO Christian Sewing since 2018, the bank has shifted focus toward cost-cutting, digital transformation, and strengthening its core European operations, while its asset management arm, DWS, oversees hundreds of billions in investments. Despite a turbulent past, Deutsche Bank remains a key player in global finance, balancing its legacy with efforts to adapt to a rapidly evolving industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Crown Castle
CCI
|
+$548M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$403M |
| 3 |
iShares Biotechnology ETF
IBB
|
+$374M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$367M |
| 5 |
Medtronic
MDT
|
+$363M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$2.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.98B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$911M |
| 4 |
Merck
MRK
|
+$614M |
| 5 |
Johnson & Johnson
JNJ
|
+$593M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.13% |
| 2 | Healthcare | 10.82% |
| 3 | Energy | 10.7% |
| 4 | Financials | 10.15% |
| 5 | Industrials | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Prothena Corp
PRTA
$425M
| $1.02M | ﹤0.01% |
49,012
-40,505
| -45% | -$845K |
|
|
HTLF
3027
DELISTED
Heartland Financial USA, Inc.
HTLF
| $1.01M | ﹤0.01% |
37,371
+25,445
| +213% | +$651K |
|
|
BIOA
3028
DELISTED
BioAmber Inc.
BIOA
| $1.01M | ﹤0.01% |
120,512
+18,000
| +18% | +$164K |
|
|
TXTR
3029
DELISTED
TEXTURA CORPORATION COM
TXTR
| $1.01M | ﹤0.01% |
35,519
-2,849
| -7% | -$72.8K |
|
3030
Fabrinet
FN
$15.6B
| $1M | ﹤0.01% |
56,645
+13,531
| +31% | +$225K |
|
3031
Rush Enterprises Class A
RUSHA
$6.2B
| $1M | ﹤0.01% |
70,499
+44,289
| +169% | +$679K |
|
3032
Cohen & Steers Select Preferred & Income Fund
PSF
$234M
| $1M | ﹤0.01% |
38,965
+2,288
| +6% | +$59.6K |
|
3033
PUT
Amazon
AMZN
$2.92T
| $999K | ﹤0.01% |
64,440
+26,220
| +69% | +$409K |
|
|
RGLS
3034
DELISTED
Regulus Therapeutics
RGLS
| $999K | ﹤0.01% |
520
+399
| +330% | +$710K |
|
|
PZN
3035
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $999K | ﹤0.01% |
105,740
+10,896
| +11% | +$103K |
|
|
EXK
3036
Endeavour Silver
EXK
$2.23B
| $997K | ﹤0.01% |
462,099
+460,241
| +24,771% | +$1.42M |
|
3037
Madrigal Pharmaceuticals
MDGL
$10.8B
| $994K | ﹤0.01% |
10,735
-124
| -1% | -$12.8K |
|
|
BXMX
3038
DELISTED
Nuveen S&P 500 Buy-Write Income Fund
BXMX
| $992K | ﹤0.01% |
82,031
+12,478
| +18% | +$159K |
|
|
ZEN
3039
DELISTED
ZENDESK INC
ZEN
| $992K | ﹤0.01% |
40,787
+19,680
| +93% | +$463K |
|
3040
Bruker
BRKR
$9.57B
| $990K | ﹤0.01% |
50,513
-75,087
| -60% | -$1.45M |
|
3041
Invesco International Corporate Bond ETF
PICB
$355M
| $988K | ﹤0.01% |
34,808
-7,026
| -17% | -$202K |
|
3042
Foster
FSTR
$430M
| $985K | ﹤0.01% |
20,314
+3,967
| +24% | +$193K |
|
3043
PUT
Viatris
VTRS
$20.4B
| $985K | ﹤0.01% |
17,477
+5,836
| +50% | +$313K |
|
|
3044
CALL
Medtronic
MDT
$109B
| $984K | ﹤0.01% |
13,630
+13,292
| +3,933% | +$923K |
|
3045
Medifast
MED
$109M
| $984K | ﹤0.01% |
29,356
-10,249
| -26% | -$319K |
|
|
UCTT
3046
Ultra Clean Holdings
UCTT
$3.73B
| $984K | ﹤0.01% |
106,149
+105,576
| +18,425% | +$894K |
|
3047
IDT Corp
IDT
$1.64B
| $983K | ﹤0.01% |
68,615
+44,050
| +179% | +$530K |
|
|
BKMU
3048
DELISTED
Bank Mutual Corp
BKMU
| $983K | ﹤0.01% |
143,616
-56,732
| -28% | -$368K |
|
|
CAMB
3049
DELISTED
CAMBRIDGE CAP ACQUISITION CORP (DE)
CAMB
| $983K | ﹤0.01% |
101,267
+51,067
| +102% | +$501K |
|
|
ETW
3050
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund
ETW
$1.03B
| $980K | ﹤0.01% |
88,984
+13,341
| +18% | +$158K |
|
Similar funds
Deutsche Bank's Q4 2014 Portfolio in Review
As of Q4 2014, Deutsche Bank held 6,662 positions worth $162B, up 0.66% from $161B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Deutsche Bank's Q4 2014 filing shows 646 new, 2,854 increased, 1,926 reduced and 371 closed positions. Its largest new stake was UBS Group: 17,102,114 shares worth $292M. The largest sale was Invesco QQQ Trust, an estimated $2.55B.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Healthcare and Energy.
- Deutsche Bank's largest Q4 2014 buy was UBS Group: 17,102,114 shares worth $292M.
- Deutsche Bank added most to Crown Castle in Q4 2014, an estimated $548M increase.
- Deutsche Bank's biggest Q4 2014 reduction was Invesco QQQ Trust, cutting an estimated $2.55B.
- Deutsche Bank fully exited KINDER MORGAN ENER PNTRS L.P. in Q4 2014, selling an estimated $557M.
- Deutsche Bank's ten largest holdings make up 10% of its $162B portfolio in Q4 2014.
- Deutsche Bank opened 646 new positions and closed 371 in Q4 2014.
- Deutsche Bank's portfolio value rose 0.66% quarter-over-quarter to $162B.
Based on Deutsche Bank's 13F filing for Q4 2014, filed 13 Feb 2015.